Virbac has launched Kriptazen, a non-antibiotic, halofuginone-based medicine for newborn calves, to prevent or reduce diarrhoea caused by Cryptosporidium parvum.

Kriptazen is supplied with a twist-adjustable and weight-graduated dosing pump which means farmers can administer a precise dose up to 60kg without having to calculate it in ml’s first. Virbac says this will help to reduce the risk of incorrect dosing and toxicity issues.

Virbac’s Technical Product Manager Rosie Naylor said: "We are delighted to bring Kriptazen to the market. The trusted active halofuginone, along with the innovative weight graduated dosing pump, provides practices with added peace of mind when it comes to treatment."

For more information, contact your Virbac Territory Manager.

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.